One is an siRNA biologic, the other an oral agent, but both lowered Lp(a) levels by 80% or more in ASCVD patients.

A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of ...

Some antibiotics can cause a yeast infection. Learn more about how antibiotics cause yeast infections, risk factors for yeast infections, and how to treat and prevent them.

New York is opening the floodgates for more medical providers to administer fluoride to kids as President-elect Donald ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

Left atrial appendage closure is an alternative strategy for stroke prophylaxis, Wazni and colleagues noted. "The safety and ...

A nasal spray would be a workaround for drug resistance seen with oral diuretics, with the potential to reduce hospital ...

Boston Scientific (NYSE:BSX) announced positive three-year primary endpoint results from a clinical trial of its Watchman FLX ...

A Phase 2 trial testing oral ROCK inhibitor Bravyl in people with ALS is now fully enrolled at its highest dosing group.

Until my mid-40s, my approach to gum health was, at best, sporadic. I had always suspected that flossing was one of those ...

In October, Michael Markiewicz, DDS, MD, MPH, professor and Feagans Endowed Chair of the Department of Oral and Maxillofacial Surgery at ... they work with their physicians to fine tune their therapy ...